PROTEOVANT
Roivant Sciences GmbH
Application Filed: 2021-07-30
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90858111 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Fross Zelnick Lehrman & Zissu, P.C. |
| Attorney Name | Allison Strickland Ricketts |
| Attorney Docket Number | ROIV 2109489 |
Timeline
| 2021-07-30 | Application Filed |
| 2021-08-03 | Location: NEW APPLICATION PROCESSING |
| 2021-08-03 | Status: Live/Pending |
| 2021-08-03 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Roivant Sciences GmbH |
| Entity Statement | gesellschaft mit beschränkter haftung (gmbh) |
| Address | Viaduktstrasse 8 Basel CH 4051 |
| Legal Entity Type | |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for human use; biologic preparations for medical and therapeutic purposes; pharmaceutical and biological preparations for treatment and prevention of cancer and for the treatment and prevention of auto-immune diseases and disorders and central nervous system and neurological diseases and disorders |
| GS0051 | Pharmaceutical preparations for human use comprising small molecules for degrading disease-causing cellular proteins for prevention and treatment of oncological, allergy and immunological, neurological, cardiac, dermatological, endocrinological, gastroenterological, hematological, infectious, genetic, nephrological, gynecological, ophthalmological, orthopedic, otorhinolaryngological, podiatric, psychiatric, pulmonological, respiratory, rheumatological, and urological diseases and disorders; biologic preparations for medical and therapeutic purposes comprising small molecules for degrading disease-causing cellular proteins for prevention and treatment of oncological, allergy and immunological, neurological, cardiac, dermatological, endocrinological, gastroenterological, hematological, infectious, genetic, nephrological, gynecological, ophthalmological, orthopedic, otorhinolaryngological, podiatric, psychiatric, pulmonological, respiratory, rheumatological, and urological diseases and disorders; pharmaceutical and biological preparations for treatment and prevention of cancer and for the treatment and prevention of auto-immune diseases and disorders and central nervous system and neurological diseases and disorders |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2021-08-03 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-09-27 | 2 NWOS I:Incoming Correspondence |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2021-08-04 | 3 PARI I:Incoming Correspondence |
| ASSIGNED TO LIE | 2021-10-04 | 4 ALIE A:Allowance for Publication |
| PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | 2021-10-05 | 5 AMPX O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2022-04-27 | 6 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2022-04-27 | 7 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2022-04-27 | 8 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-04-27 | 9 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-10-27 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-10-27 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-10-28 | 12 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2022-11-29 | 13 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2022-11-29 | 14 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2022-11-29 | 15 GNFN O:Outgoing Correspondence |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2023-02-14 | 16 ERFR I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-02-14 | 17 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-02-15 | 18 TEME I:Incoming Correspondence |
| ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED | 2023-02-28 | 19 RRDX W: |
| ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED | 2023-02-28 | 20 RDX1 O:Outgoing Correspondence |
| NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED | 2023-02-28 | 21 RDX3 O:Outgoing Correspondence |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2023-03-17 | 22 ERFR I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-03-17 | 23 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-03-17 | 24 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-04-03 | 25 CNSA O:Outgoing Correspondence |
| ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | 2023-04-07 | 26 ERRR O:Outgoing Correspondence |
| ELECTRONIC RECORD REVIEW COMPLETE | 2023-04-12 | 27 FIXD O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-04-26 | 28 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2023-05-16 | 29 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-05-16 | 30 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2023-08-01 | 31 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-08-01 | 32 NRCC E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 